1. "How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor". Issue 1 (January 2022) Authors: Albayrak, Haluk Cihad; Gürler, Fatih; Sütçüoğlu, Osman; Akyürek, Nalan; Özet, Ahmet Journal: Anti-cancer drugs Issue: Volume 33:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. (cRGD)2 peptides modified nanoparticles increase tumor-targeting therapeutic effects by co-delivery of albendazole and iodine-131. Issue 1 (January 2022) Authors: Liu, Shengli; Liu, Honglian; Sun, Hao; Deng, Shengming; Yue, Ling; Weng, Zhen; Yang, Jianfeng; Zuo, Bin; He, Yang; Zhang, Bin Journal: Anti-cancer drugs Issue: Volume 33:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1st International Conference on Natural Products for Cancer Prevention and Therapy 31 August–2 September 2015 Istanbul, Turkey: Erratum. Issue 1 (January 2016) Journal: Anti-cancer drugs Issue: Volume 27:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation. Issue 4 (April 2017) Authors: Park, Ga B.; Chung, Yoon H.; Kim, Daejin Journal: Anti-cancer drugs Issue: Volume 28:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Issue 9 (14th September 2022) Authors: Tian, Dazhi; Yu, Yang; Zhang, Li; Sun, Jisan; Jiang, Wentao Journal: Anti-cancer drugs Issue: Volume 33:Issue 9(2022) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2′-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells. Issue 1 (January 2015) Authors: Ismail, Bassel; Fagnere, Catherine; Limami, Youness; Ghezali, Lamia; Pouget, Christelle; Fidanzi, Chloë; Ouk, Catherine; Gueye, Rokhaya; Beneytout, Jean-Louis; Duroux, Jean-Luc; Diab-Assaf, Mona; Leger, David Y.; Liagre, Bertrand Journal: Anti-cancer drugs Issue: Volume 26:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2′-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells. Issue 1 (January 2015) Authors: Ismail, Bassel; Fagnere, Catherine; Limami, Youness; Ghezali, Lamia; Pouget, Christelle; Fidanzi, Chloë; Ouk, Catherine; Gueye, Rokhaya; Beneytout, Jean-Louis; Duroux, Jean-Luc; Diab-Assaf, Mona; Leger, David Y.; Liagre, Bertrand Journal: Anti-cancer drugs Issue: Volume 26:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 3, 3′-diindolylmethane exerts antiproliferation and apoptosis induction by TRAF2-p38 axis in gastric cancer. Issue 2 (February 2021) Authors: Ye, Yang; Ye, Fen; Li, Xue; Yang, Qi; Zhou, Jianwei; Xu, Wenrong; Aschner, Michael; Lu, Rongzhu; Miao, Shuhan Journal: Anti-cancer drugs Issue: Volume 32:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3, 3′-Diindolylmethane induces ferroptosis by BAP1–IP3R axis in BGC-823 gastric cancer cells. Issue 4 (21st February 2022) Authors: Ye, Yang; Li, Xue; Feng, Guoquan; Ma, Ying; Ye, Fen; Shen, Haijun; Sun, Kang; Lu, Rongzhu; Miao, Shuhan Journal: Anti-cancer drugs Issue: Volume 33:Issue 4(2022) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2. Issue 7 (August 2017) Authors: Can, Zhou; Lele, Song; Zhirui, Zhang; Qiong, Pan; Yuzhong, Chen; Lingling, Liu; Surong, Zhao; Yiming, Sun; Pei, Zhang; Chenchen, Jiang; Liu, Hao Journal: Anti-cancer drugs Issue: Volume 28:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗